← Leaderboards
Daniel W Lin
Fred Hutchinson Cancer Research Center
$11,737,232
Attributed
$16,793,433
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,793,433 · 8
By mechanism
R01$8,141,379 · 3
U01$6,672,861 · 1
UH3$1,019,400 · 1
K23$633,555 · 1
P50$326,238 · 2
Top collaborators
- Beatrice S Knudsen6 shared
- Ruth D Etzioni5 shared
- David F Penson5 shared
- Yingye Zheng4 shared
- Mark A. Rubin3 shared
- Juan Miguel Mosquera2 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Chu Chen$16,558,917
- Noel Weiss$6,022,649
- Janet L Stanford$12,426,000
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateMonitorProstateMalignant NeoplasmsRecommendationBaseDiagnosisBiopsyTissuesCessation Of LifeCohortSurveillance StudyMaleNewly DiagnosedCostProtocols DocumentationClinical TrialsDesignQuality Of LifeClinical ManagementDisease ProgressionDecision MakingTumor ProgressionFuture
Grant awards (34)
Developmental Research Program$120,683
P50 · FY2024 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$1,277,646
U01 · FY2023 · CA · contact PI
Developmental Research Program$122,369
P50 · FY2023 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$1,277,983
U01 · FY2022 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$683,942
U01 · FY2021 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$639,455
U01 · FY2021 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$194,491
UH3 · FY2021 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$131,912
UH3 · FY2021 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$1,259,328
U01 · FY2020 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$327,141
UH3 · FY2020 · CA · contact PI
Career Enhancement Program$83,186
P50 · FY2020 · CA · contact PI
Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research$1,534,507
U01 · FY2019 · CA · contact PI
Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance$365,856
UH3 · FY2019 · CA · contact PI
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2018 · CA
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2017 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies$565,071
R01 · FY2017 · CA
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2016 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies$567,040
R01 · FY2016 · CA
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2015 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies$576,083
R01 · FY2015 · CA
Precision Medicine Approach to Prostate Cancer Active Surveillance$747,152
R01 · FY2014 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies$508,879
R01 · FY2014 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies$637,795
R01 · FY2013 · CA
In vivo effects of sulforaphane supplementation on normal human prostate$121,376
R01 · FY2013 · CA · contact PI
In vivo effects of sulforaphane supplementation on normal human prostate$550,777
R01 · FY2012 · CA · contact PI
In vivo effects of sulforaphane supplementation on normal human prostate$1
R01 · FY2011 · CA · contact PI
In vivo effects of sulforaphane supplementation on normal human prostate$536,166
R01 · FY2010 · CA · contact PI
In vivo effects of sulforaphane supplementation on normal human prostate$95,983
R01 · FY2010 · CA · contact PI
In vivo effects of sulforaphane supplementation on normal human prostate$454,948
R01 · FY2009 · CA · contact PI
In Vivo Molecular Effects of Prostatic COX-2 Inhibition$126,873
K23 · FY2007 · DK · contact PI
In Vivo Molecular Effects of Prostatic COX-2 Inhibition$126,873
K23 · FY2006 · DK · contact PI
In Vivo Molecular Effects of Prostatic COX-2 Inhibition$126,873
K23 · FY2005 · DK
In Vivo Molecular Effects of Prostatic COX-2 Inhibition$126,873
K23 · FY2004 · DK
In Vivo Molecular Effects of Prostatic COX-2 Inhibition$126,063
K23 · FY2003 · DK